J. Chuck Harrell

5.8k total citations
78 papers, 3.6k citations indexed

About

J. Chuck Harrell is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, J. Chuck Harrell has authored 78 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 33 papers in Molecular Biology and 30 papers in Cancer Research. Recurrent topics in J. Chuck Harrell's work include Cancer Cells and Metastasis (38 papers), Cancer Genomics and Diagnostics (17 papers) and HER2/EGFR in Cancer Research (12 papers). J. Chuck Harrell is often cited by papers focused on Cancer Cells and Metastasis (38 papers), Cancer Genomics and Diagnostics (17 papers) and HER2/EGFR in Cancer Research (12 papers). J. Chuck Harrell collaborates with scholars based in United States, Spain and Canada. J. Chuck Harrell's co-authors include Charles M. Perou, Kathryn B. Horwitz, Kenneth S. Korach, Carol A. Sartorius, Sylvia C. Hewitt, Paul Jedlicka, Wendy W. Dye, Heide L. Ford, Aleix Prat and Peter Kabos and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

J. Chuck Harrell

75 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Chuck Harrell United States 35 1.9k 1.8k 1.1k 668 467 78 3.6k
Dorraya El‐Ashry United States 31 1.7k 0.9× 1.7k 0.9× 972 0.9× 789 1.2× 275 0.6× 52 3.1k
Junichi Kurebayashi Japan 37 1.8k 0.9× 1.9k 1.1× 999 0.9× 734 1.1× 425 0.9× 157 3.8k
Marja T. Nevalainen United States 37 1.8k 0.9× 1.7k 0.9× 876 0.8× 728 1.1× 1.0k 2.1× 77 3.7k
Sophie Vacher France 39 2.6k 1.3× 1.5k 0.8× 1.5k 1.3× 448 0.7× 587 1.3× 142 4.5k
Andrew H. Sims United Kingdom 39 3.0k 1.6× 1.8k 1.0× 1.6k 1.4× 432 0.6× 562 1.2× 127 4.9k
Clodia Osipo United States 30 2.0k 1.1× 1.4k 0.8× 718 0.6× 616 0.9× 242 0.5× 54 3.1k
Youyong Lu China 35 2.8k 1.5× 1.4k 0.8× 1.5k 1.4× 418 0.6× 443 0.9× 122 4.4k
Somaira Nowsheen United States 37 2.1k 1.1× 1.3k 0.7× 480 0.4× 253 0.4× 357 0.8× 74 3.2k
Todd W. Miller United States 34 2.5k 1.3× 1.8k 1.0× 966 0.9× 604 0.9× 1.2k 2.5× 79 4.1k
David J. Mulholland United States 28 2.9k 1.5× 1.2k 0.7× 937 0.8× 451 0.7× 1.2k 2.6× 50 4.4k

Countries citing papers authored by J. Chuck Harrell

Since Specialization
Citations

This map shows the geographic impact of J. Chuck Harrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Chuck Harrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Chuck Harrell more than expected).

Fields of papers citing papers by J. Chuck Harrell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Chuck Harrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Chuck Harrell. The network helps show where J. Chuck Harrell may publish in the future.

Co-authorship network of co-authors of J. Chuck Harrell

This figure shows the co-authorship network connecting the top 25 collaborators of J. Chuck Harrell. A scholar is included among the top collaborators of J. Chuck Harrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Chuck Harrell. J. Chuck Harrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vangala, Janakiram R., et al.. (2023). Evaluation of the NRF1-proteasome axis as a therapeutic target in breast cancer. Scientific Reports. 13(1). 15843–15843. 4 indexed citations
2.
Turner, Scott A., Andrea Ferreira‐Gonzalez, Amy L. Olex, et al.. (2023). Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast Cancer. Cancers. 15(12). 3179–3179. 3 indexed citations
3.
Olex, Amy L., Mohammad A. Alzubi, Scott A. Turner, et al.. (2023). Discovering Synergistic Compounds with BYL-719 in PI3K Overactivated Basal-like PDXs. Cancers. 15(5). 1582–1582. 9 indexed citations
4.
Dozmorov, Mikhail G., Amy L. Olex, Abhijit Chakraborty, et al.. (2023). Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft. Scientific Reports. 13(1). 5420–5420. 6 indexed citations
5.
Jacob, Sheeba, Jinyang Cai, Konstantinos V. Floros, et al.. (2022). Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer models. PNAS Nexus. 1(5). pgac232–pgac232. 6 indexed citations
6.
Kanak, Mazhar A., et al.. (2022). Single-Molecule Sensor for High-Confidence Detection of miRNA. ACS Sensors. 7(4). 1086–1094. 25 indexed citations
7.
Dozmorov, Mikhail G., Katarzyna M. Tyc, Nathan C. Sheffield, et al.. (2021). Chromatin conformation capture (Hi-C) sequencing of patient-derived xenografts: analysis guidelines. GigaScience. 10(4). 5 indexed citations
8.
Lundberg, Arian, Linda S. Lindström, J. Chuck Harrell, et al.. (2017). Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts. Clinical Cancer Research. 23(24). 7512–7520. 34 indexed citations
9.
Medler, Terry R., et al.. (2016). HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth. Molecular Cancer Research. 14(10). 994–1008. 36 indexed citations
10.
Wahdan-Alaswad, Reema S., J. Chuck Harrell, Zeying Fan, et al.. (2016). Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer. Cell Cycle. 15(8). 1046–1059. 61 indexed citations
11.
Voduc, K. David, Torsten O. Nielsen, Charles M. Perou, et al.. (2015). αB-crystallin expression in breast cancer is associated with brain metastasis. npj Breast Cancer. 1(1). 28 indexed citations
12.
Bockhorn, Jessica, Aleix Prat, Ya-Fang Chang, et al.. (2014). Differentiation and Loss of Malignant Character of Spontaneous Pulmonary Metastases in Patient-Derived Breast Cancer Models. Cancer Research. 74(24). 7406–7417. 33 indexed citations
13.
Harrell, J. Chuck, Aleix Prat, Joel S. Parker, et al.. (2011). Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse. Breast Cancer Research and Treatment. 132(2). 523–535. 166 indexed citations
14.
Elloumi, Fathi, Erick Romàn-Pèrez, Delisha A. Stewart, et al.. (2010). Interactions with Fibroblasts Are Distinct in Basal-Like and Luminal Breast Cancers. Molecular Cancer Research. 9(1). 3–13. 90 indexed citations
15.
Spillman, Monique A., Nicole Manning, Wendy W. Dye, et al.. (2010). Tissue-Specific Pathways for Estrogen Regulation of Ovarian Cancer Growth and Metastasis. Cancer Research. 70(21). 8927–8936. 53 indexed citations
16.
Micalizzi, Douglas S., Kimberly Christensen, Paul Jedlicka, et al.. (2009). The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-β signaling. Journal of Clinical Investigation. 119(9). 2678–2690. 196 indexed citations
17.
Harrell, J. Chuck, Wendy W. Dye, Djuana M. E. Harvell, et al.. (2007). Estrogen Insensitivity in a Model of Estrogen Receptor–Positive Breast Cancer Lymph Node Metastasis. Cancer Research. 67(21). 10582–10591. 39 indexed citations
18.
Jacobsen, Britta M., J. Chuck Harrell, Paul Jedlicka, et al.. (2006). Spontaneous Fusion with, and Transformation of Mouse Stroma by, Malignant Human Breast Cancer Epithelium. Cancer Research. 66(16). 8274–8279. 70 indexed citations
19.
Hewitt, Sylvia C., Wayne P. Bocchinfuso, J. Chuck Harrell, et al.. (2002). Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu.. PubMed. 62(10). 2798–805. 41 indexed citations
20.
Harrell, J. Chuck, et al.. (2002). Genomic structure and identification of a truncated variant message of the mouse estrogen receptor α gene. Gene. 294(1-2). 239–247. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dorraya El‐Ashry Breakdown of academic impact, for papers by Junichi Kurebayashi Breakdown of academic impact, for papers by Marja T. Nevalainen Breakdown of academic impact, for papers by Sophie Vacher Breakdown of academic impact, for papers by Andrew H. Sims Breakdown of academic impact, for papers by Clodia Osipo Breakdown of academic impact, for papers by Youyong Lu Breakdown of academic impact, for papers by Somaira Nowsheen Breakdown of academic impact, for papers by Todd W. Miller Breakdown of academic impact, for papers by David J. Mulholland
Rankless by CCL
2026